VanEck Associates’s Calumet Specialty Products CLMT Stock Holding History

VanEck Associates’s Portfolio CLMT Stock Details CLMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.83M	Buy	50,802 +4,973	+11%	+$167K	﹤0.01%	1052
2026 Q1	$1.65M	Buy	+45,829	New	+$1.19M	﹤0.01%	1023
2025 Q4	–	Sell	-17,035	Closed	-$311K	–	1426
2025 Q3	$311K	Sell	17,035 -1,503	-8%	-$24.7K	﹤0.01%	1241
2025 Q2	$292K	Buy	+18,538	New	+$236K	﹤0.01%	1214
2017 Q1	–	Sell	-250,817	Closed	-$1M	–	888
2016 Q4	$1M	Sell	250,817 -8,823	-3%	-$36K	0.01%	481
2016 Q3	$1.17M	Sell	259,640 -21,497	-8%	-$111K	0.01%	473
2016 Q2	$1.38M	Buy	281,137 +1,217	+0.4%	+$6.9K	0.01%	421
2016 Q1	$3.29M	Buy	+279,920	New	+$3.89M	0.02%	284
2015 Q4	–	Sell	-2,208	Closed	-$54K	–	771
2015 Q3	$54K	Buy	+2,208	New	+$57.4K	﹤0.01%	675

Other funds holding CLMT

TSC

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WDOM

Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AAA

Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

VanEck Associates's CLMT Position: Q2 2026 in Review

VanEck Associates increased its Calumet Specialty Products (CLMT) stake by 11% in Q2 2026, buying an estimated $167K and bringing the position to 50,802 shares worth $1.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

VanEck Associates first reported a position in CLMT in Q3 2015 and has held it in 9 quarters since. The position peaked at $3.29M in Q1 2016. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

VanEck Associates held 50,802 shares of Calumet Specialty Products worth $1.83M as of Q2 2026.
VanEck Associates bought 4,973 Calumet Specialty Products shares in Q2 2026, an estimated $167K.
Calumet Specialty Products made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1052 holding.
VanEck Associates first reported a position in Calumet Specialty Products in Q3 2015 and has held it in 9 quarters since.
VanEck Associates's Calumet Specialty Products position peaked at $3.29M in Q1 2016.
188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.